Ticker Symbol: INTI
Inhibitor Therapeutics Inc
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001042418
Company Profile
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8731
Address: 4830 W. Kennedy Blvd.
Website: http://www.hedgepathpharma.com/
CEO: Nicholas Virca
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.04
Change:
$0.00
(
17.78%)
Days Range: $0.04 - $0.04
Beta: -
52wk. High: $0.09
52wk. Low: $0.01
Ytd. Change -45.78%
50 Day Moving Average: $0.04
200 Day Moving Average: $0.03
Shares Outstanding: 171968134
Valuation
Market Cap: 729.1M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A